TRDA Entrada Therapeutics, Inc. - Common Stock
TRDA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
TRDA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
TRDA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 5 35,7%
- Kauf 7 50,0%
- Halten 2 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
4 Analysten · 2026-08-15Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.01 | $-1.07 | 0.06% |
| 31. März 2026 | $-0.95 | $-1.06 | 0.11% |
| 31. Dezember 2025 | $-0.94 | $-1.17 | 0.23% |
| 30. September 2025 | $-1.06 | $-0.96 | -0.10% |
| 30. Juni 2025 | $-1.04 | $-0.86 | -0.18% |
| 31. März 2025 | $-0.42 | $-0.80 | 0.38% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| AVXL | $771M | -16.5 | -36.1% | -991.4% | -47.7% | — |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | — |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $211M | $129M | |
| R&D Expense | $142M | $125M | $100M | |
| SG&A Expense | $41M | $38M | $32M | |
| Operating Expenses | $183M | $164M | $132M | |
| Operating Income | $-158M | $47M | $-3M | |
| Other Non-op | $15M | $19M | $15M | |
| Income Tax | $924.0K | $859.0K | $19M | |
| Net Income | $-144M | $66M | $-7M | |
| EPS (Basic) | $-3.47 | $1.76 | $-0.20 | |
| EPS (Diluted) | $-3.47 | $1.68 | $-0.20 | |
| Shares (Basic) | 41,371,486 | 37,306,363 | 33,050,319 | |
| Shares (Diluted) | 41,371,486 | 39,003,169 | 33,050,319 | |
| EBITDA | $-158M | $47M | $-3M |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $90M | $101M | $68M | |
| Prepaid Expense | $9M | $16M | $12M | |
| Current Assets | $306M | $440M | $370M | |
| PP&E (Net) | $7M | $11M | $11M | |
| PP&E (Gross) | $17M | $20M | $17M | |
| Accum. Depreciation | $10M | $9M | $6M | |
| Other Non-current Assets | $70.0K | $284.0K | $3M | |
| Total Assets | $377M | $526M | $469M | |
| Accounts Payable | $2M | $4M | $3M | |
| Accrued Liabilities | $18M | $13M | $11M | |
| Current Liabilities | $24M | $39M | $159M | |
| Capital Leases | $47M | $52M | $60M | |
| Total Liabilities | $71M | $98M | $227M | |
| Common Stock | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $579M | $558M | $437M | |
| Retained Earnings | $-273M | $-129M | $-195M | |
| AOCI | $652.0K | $-43.0K | $195.0K | |
| Stockholders' Equity | $306M | $429M | $242M | |
| Liabilities + Equity | $377M | $526M | $469M | |
| Shares Outstanding | 38,284,221 | 37,574,538 | 33,437,296 |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $20M | $18M | $13M | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-129M | $-42M | $140M | |
| CapEx | $1M | $3M | $6M | |
| Investing Cash Flow | $117M | $-28M | $-138M | |
| Financing Cash Flow | $887.0K | $103M | $21M | |
| Net Change in Cash | $-11M | $34M | $22M | |
| Taxes Paid | $2M | $5M | $15M | |
| Free Cash Flow | $-130M | $-45M | $134M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -621.1% | 22.3% | -2.5% | |
| Net Margin | -565.5% | 31.1% | -5.2% | |
| EBITDA Margin | -621.1% | 22.3% | -2.5% | |
| ROA | -31.8% | 13.2% | -1.8% | |
| ROE | -41.9% | 15.4% | -2.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.5 | 11.1 | 2.3 | |
| Quick Ratio | 3.7 | 2.6 | 0.4 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.4 | 0.4 |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -87.9% | 63.4% | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $211M | $129M | |
| Net Income TTM | $-144M | $66M | $-7M | |
| Market Cap | $394M | $650M | $505M | |
| P/E | -3.0 | 10.3 | -75.5 | |
| P/S | 15.5 | 3.1 | 3.9 | |
| P/B | 1.3 | 1.5 | 2.1 | |
| P / Tangible Book | 1.3 | 1.5 | 2.1 | |
| P / Cash Flow | -3.1 | -15.6 | 3.6 | |
| P / FCF | -3.0 | -14.5 | 3.8 | |
| Earnings Yield | -33.8% | 9.7% | -1.3% |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $898.0K | $875.0K | $1M | $2M | $2M | $21M | $37M | $20M | $95M | $59M | $42M | $44M | $18M | $25M | · | $0 | |
| R&D Expense | $35M | $33M | $34M | $38M | $38M | $32M | $33M | $31M | $32M | $29M | $28M | $22M | $26M | $23M | $16M | $19M | |
| SG&A Expense | $10M | $10M | $10M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $8M | $8M | $10M | $7M | |
| Operating Expenses | $46M | $43M | $44M | $49M | $49M | $42M | $43M | $41M | $41M | $38M | $37M | $30M | $34M | $31M | $26M | $26M | |
| Operating Income | $-45M | $-42M | $-42M | $-47M | $-47M | $-22M | $-6M | $-22M | $53M | $21M | $5M | $14M | $-16M | $-6M | $-26M | $-26M | |
| Other Non-op | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $3M | $950.0K | $799.0K | |
| Income Tax | $35.0K | $38.0K | $92.0K | $654.0K | $178.0K | $0 | $-2M | $-2M | $3M | $2M | $19M | $-17M | $14M | $4M | $0 | $0 | |
| Net Income | $-43M | $-40M | $-39M | $-44M | $-43M | $-17M | $1M | $-14M | $55M | $23M | $-10M | $35M | $-26M | $-7M | $-25M | $-25M | |
| EPS (Basic) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.61 | $0.70 | $-0.28 | $1.07 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| EPS (Diluted) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.55 | $0.68 | $-0.23 | $1.02 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| Shares (Basic) | 42,221,665 | 41,836,275 | -82,503,565 | 41,462,567 | 41,338,752 | 41,073,732 | -71,000,860 | 40,629,602 | 34,180,549 | 33,497,072 | -65,768,587 | 33,281,287 | 33,163,320 | 32,374,299 | -62,526,962 | 31,298,052 | |
| Shares (Diluted) | 42,221,665 | 41,836,275 | -82,503,565 | 41,462,567 | 41,338,752 | 41,073,732 | -71,924,387 | 40,629,602 | 35,507,029 | 34,790,925 | -67,262,751 | 34,775,451 | 33,163,320 | 32,374,299 | -62,526,962 | 31,298,052 | |
| EBITDA | $-45M | $-42M | · | $-47M | $-47M | $-22M | · | $-22M | $53M | $21M | · | $14M | $-16M | · | · | $-26M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $76M | $90M | $93M | $72M | $68M | $101M | $78M | $185M | $68M | $68M | $52M | $80M | $228M | $45M | $53M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $162M | |
| Prepaid Expense | $9M | $11M | $9M | $10M | $14M | $19M | $16M | $13M | $12M | $9M | $12M | $24M | $10M | $16M | $21M | $19M | |
| Current Assets | $233M | $267M | $306M | $338M | $369M | $403M | $440M | $465M | $490M | $414M | $370M | $383M | $390M | $434M | $210M | $235M | |
| PP&E (Net) | $6M | $7M | $7M | $8M | $10M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $9M | $8M | $7M | |
| PP&E (Gross) | $16M | $17M | $17M | $19M | $21M | $21M | $20M | $19M | $19M | $18M | $17M | $16M | $15M | $13M | $11M | $10M | |
| Accum. Depreciation | $11M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | $3M | |
| Other Non-current Assets | $118.0K | $90.0K | $70.0K | $163.0K | $199.0K | $239.0K | $284.0K | $746.0K | $747.0K | $3M | $3M | $3M | $538.0K | $14M | $5M | $954.0K | |
| Total Assets | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $2M | $2M | $4M | $1M | $2M | $3M | $3M | $752.0K | $2M | $6M | $6M | $1M | |
| Accrued Liabilities | $13M | $12M | $18M | $16M | $12M | $8M | $13M | $13M | $11M | $9M | $11M | $10M | $7M | $12M | $8M | $12M | |
| Current Liabilities | $21M | $19M | $24M | $24M | $20M | $18M | $39M | $71M | $86M | $174M | $159M | $165M | $126M | $148M | $22M | $22M | |
| Capital Leases | $44M | $45M | $47M | $48M | $49M | $50M | $52M | $54M | $56M | $58M | $60M | $62M | $66M | $9M | $18M | $20M | |
| Total Liabilities | $65M | $65M | $71M | $72M | $69M | $69M | $98M | $132M | $152M | $241M | $227M | $238M | $287M | $246M | $40M | $41M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $589M | $583M | $579M | $574M | $569M | $564M | $558M | $552M | $547M | $441M | $437M | $433M | $429M | $425M | $403M | $400M | |
| Retained Earnings | $-356M | $-313M | $-273M | $-234M | $-190M | $-147M | $-129M | $-130M | $-116M | $-171M | $-195M | $-185M | $-221M | $-195M | $-188M | $-164M | |
| AOCI | $66.0K | $246.0K | $652.0K | $621.0K | $400.0K | $437.0K | $-43.0K | $972.0K | $-329.0K | $-246.0K | $195.0K | $-496.0K | $-1M | $-642.0K | $-2M | $-3M | |
| Stockholders' Equity | $233M | $271M | $306M | $341M | $380M | $417M | $429M | $422M | $430M | $269M | $242M | $247M | $207M | $230M | $213M | $233M | |
| Liabilities + Equity | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Shares Outstanding | 38,936,669 | 38,820,616 | 38,284,221 | 38,219,232 | 38,033,970 | 37,942,283 | 37,574,538 | 37,400,499 | 37,172,496 | 33,604,053 | 33,437,296 | 33,340,216 | 33,205,693 | 33,133,736 | 31,394,767 | 31,325,373 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-32M | $-42M | $-32M | $-28M | $-29M | $-39M | $-32M | $-24M | $40M | $-26M | $-4M | $-24M | $-35M | $203M | $-27M | $-27M | |
| CapEx | $11.0K | $44.0K | $-207.0K | $-171.0K | $275.0K | $1M | $635.0K | $639.0K | $1M | $838.0K | $976.0K | $1M | $2M | $2M | $708.0K | $810.0K | |
| Investing Cash Flow | $55M | $27M | $29M | $49M | $34M | $5M | $53M | $-83M | $-24M | $26M | $19M | $-4M | $-113M | $-40M | $19M | $-10M | |
| Stock Issued | · | · | · | $0 | · | · | · | $-392.0K | $100M | $0 | · | $0 | $0 | $19M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $350.0K | $100.0K | $192.0K | $8.0K | $337.0K | $350.0K | $1M | $-11.0K | $101M | $206.0K | $690.0K | $368.0K | $443.0K | $20M | $358.0K | $60.0K | |
| Net Change in Cash | $23M | $-15M | $-3M | $21M | $5M | $-33M | $23M | $-107M | $117M | $834.0K | $16M | $-28M | $-148M | $182M | $-8M | $-38M | |
| Free Cash Flow | · | $-42M | · | · | · | $-40M | · | · | · | $-26M | · | · | · | · | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| Net Margin | -4762.0% | -4539.1% | · | -2734.4% | -2210.4% | -84.4% | · | -71.7% | 58.1% | 39.7% | · | 81.1% | -142.7% | · | · | · | |
| EBITDA Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| ROA | -11.4% | -9.7% | · | -9.1% | -8.4% | -3.5% | · | -2.7% | 10.2% | 4.8% | · | 9.3% | -6.6% | · | · | -12.4% | |
| ROE | -14.0% | -11.5% | · | -11.6% | -10.7% | -5.1% | · | -4.2% | 17.3% | 9.4% | · | 14.8% | -11.2% | · | · | -31.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 13.9 | · | 14.1 | 18.6 | 21.9 | · | 6.6 | 5.7 | 2.4 | · | 2.3 | 3.1 | · | · | 10.9 | |
| Quick Ratio | 4.6 | 4.0 | · | 3.9 | 3.7 | 3.7 | · | 1.1 | 2.2 | 0.4 | · | 0.3 | 0.6 | · | · | 10.0 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.0 | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $25M | · | $44M | $137M | $194M | · | $217M | $216M | $146M | · | $87M | $43M | $25M | · | · | |
| Net Income TTM | $-170M | $-144M | · | $-119M | $-19M | $47M | · | $100M | $88M | $26M | · | $-22M | $-81M | $-77M | · | $-84M | |
| Market Cap | $287M | $490M | · | $222M | $256M | $343M | · | $598M | $530M | $476M | · | $527M | $503M | · | · | $494M | |
| P/E | -1.8 | -3.6 | · | -2.0 | -25.8 | 6.2 | · | 5.5 | 5.8 | 20.0 | · | -20.5 | -6.0 | -5.9 | · | -1.3 | |
| P/S | 53.7 | 19.6 | · | 5.1 | 1.9 | 1.8 | · | 2.8 | 2.5 | 3.3 | · | 6.0 | 11.6 | · | · | · | |
| P/B | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | · | · | 2.1 | |
| P / Tangible Book | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | 2.1 | · | 2.1 | |
| P / Cash Flow | · | -11.8 | · | · | · | -8.9 | · | · | · | -18.7 | · | · | · | · | · | · | |
| P / FCF | · | -11.7 | · | · | · | -8.7 | · | · | · | -18.1 | · | · | · | · | · | · | |
| Earnings Yield | -55.2% | -27.5% | · | -49.5% | -3.9% | 16.2% | · | 18.1% | 17.3% | 5.0% | · | -4.9% | -16.7% | -16.8% | · | -76.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $25M | $211M | $129M | — | — |
| Betriebsgewinnmarge % | -621.1% | 22.3% | -2.5% | — | — |
| Nettoergebnis | $-144M | $66M | $-7M | $-95M | $-51M |
| Verwässerte EPS | $-3.47 | $1.68 | $-0.20 | $-3.02 | $-8.16 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 12.5 | 11.1 | 2.3 | — | 44.5 |
| Quick Ratio | 3.7 | 2.6 | 0.4 | — | 43.3 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-130M | $-45M | $134M | — | $-55M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 137 Einreicher · $224.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 34 (+12 vs. Vorquartal) | 16 (+4 vs. Vorquartal) | 47 (+2 vs. Vorquartal) | 30 (0 vs. Vorquartal) | +2.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $37.335.293 | 5.072.730 | 16,63% | Aktien |
| 5AM Venture Management, LLC | $29.854.949 | 4.056.379 | 13,30% | Aktien |
| MPM ASSET MANAGEMENT LLC | $25.410.160 | 4.381.062 | 11,32% | Aktien |
| VANGUARD GROUP INC | $15.056.160 | 1.464.607 | 6,71% | Aktien |
| Merck & Co., Inc. | $12.804.692 | 1.739.768 | 5,71% | Aktien |
| StepStone Group LP | $9.607.316 | 761.277 | 4,28% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.344.506 | 1.269.634 | 4,16% | Aktien |
| MPM BIOIMPACT LLC | $9.222.470 | 1.253.053 | 4,11% | Aktien |
| TCG Crossover Management, LLC | $7.803.293 | 1.060.230 | 3,48% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $7.024.524 | 954.419 | 3,13% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $5.622.738 | 763.959 | 2,51% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $5.114.103 | 694.851 | 2,28% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.548.555 | 617.863 | 2,03% | Aktien |
| STATE STREET CORP | $4.391.543 | 596.677 | 1,96% | Aktien |
| JPMORGAN CHASE & CO | $3.170.992 | 411.283 | 1,41% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $2.523.148 | 342.819 | 1,12% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.233.458 | 303.459 | 1,00% | Aktien |
| Nantahala Capital Management, LLC | $2.212.232 | 300.575 | 0,99% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.870.397 | 254.130 | 0,83% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.450.921 | 197.136 | 0,65% | Aktien |
| Longaeva Partners L.P. | $1.436.944 | 195.237 | 0,64% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.405.760 | 191.000 | 0,63% | Aktien |
| Quantinno Capital Management LP | $1.389.855 | 188.839 | 0,62% | Aktien |
| Lynx1 Capital Management LP | $1.314.540 | 178.606 | 0,59% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.233.875 | 167.646 | 0,55% | Aktien |
| BlackRock, Inc. | $1.216.689 | 165.311 | 0,54% | Aktien |
| Woodline Partners LP | $1.071.616 | 145.600 | 0,48% | Aktien |
| Trexquant Investment LP | $1.031.452 | 140.143 | 0,46% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.022.262 | 138.894 | 0,46% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $772.800 | 105.000 | 0,34% | Aktien |
| Cubist Systematic Strategies, LLC | $711.521 | 122.676 | 0,32% | Aktien |
| XTX Topco Ltd | $701.680 | 95.337 | 0,31% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $699.524 | 95.044 | 0,31% | Aktien |
| Allspring Global Investments Holdings, LLC | $688.440 | 93.538 | 0,31% | Aktien |
| ROYCE & ASSOCIATES LP | $610.159 | 82.902 | 0,27% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $586.599 | 79.701 | 0,26% | Aktien |
| CITADEL ADVISORS LLC | $551.058 | 74.872 | 0,25% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $533.747 | 72.520 | 0,24% | Aktien |
| AMERIPRISE FINANCIAL INC | $518.107 | 70.395 | 0,23% | Aktien |
| Qube Research & Technologies Ltd | $448.018 | 60.872 | 0,20% | Aktien |
| CANTOR FITZGERALD, L. P. | $441.600 | 60.000 | 0,20% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $399.297 | 31.640 | 0,18% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $398.272 | 54.113 | 0,18% | Aktien |
| TD Asset Management Inc | $394.408 | 53.588 | 0,18% | Aktien |
| ExodusPoint Capital Management, LP | $388.365 | 52.767 | 0,17% | Aktien |
| Nan Fung Group Holdings Ltd | $361.244 | 49.082 | 0,16% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $341.519 | 46.402 | 0,15% | Aktien |
| BANK OF AMERICA CORP /DE/ | $314.265 | 42.699 | 0,14% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $281.616 | 38.263 | 0,13% | Aktien |
| HSBC HOLDINGS PLC | $278.266 | 36.470 | 0,12% | Aktien |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $276.015 | 37.502 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $270.421 | 36.743 | 0,12% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $255.296 | 34.687 | 0,11% | Aktien |
| Brevan Howard Capital Management LP | $250.012 | 33.969 | 0,11% | Aktien |
| Graham Capital Management, L.P. | $246.244 | 33.457 | 0,11% | Aktien |
| D. E. Shaw & Co., Inc. | $238.442 | 32.397 | 0,11% | Aktien |
| Odyssean, LLC | $230.405 | 31.305 | 0,10% | Aktien |
| Corton Capital Inc. | $225.324 | 38.849 | 0,10% | Aktien |
| IEQ CAPITAL, LLC | $218.437 | 29.679 | 0,10% | Aktien |
| Point72 Asset Management, L.P. | $209.760 | 28.500 | 0,09% | Aktien |
| China Universal Asset Management Co., Ltd. | $204.446 | 27.778 | 0,09% | Aktien |
| BARCLAYS PLC | $204.298 | 27.758 | 0,09% | Aktien |
| Verdad Advisers, LP | $202.400 | 27.500 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $198.661 | 26.992 | 0,09% | Aktien |
| DEUTSCHE BANK AG\ | $195.452 | 26.556 | 0,09% | Aktien |
| Voleon Capital Management LP | $186.385 | 25.324 | 0,08% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $184.000 | 25.000 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $181.395 | 24.646 | 0,08% | Aktien |
| Inscription Capital, LLC | $176.206 | 23.941 | 0,08% | Aktien |
| AlphaQuest LLC | $160.666 | 15.629 | 0,07% | Aktien |
| Mariner, LLC | $159.779 | 21.707 | 0,07% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $152.006 | 20.653 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $129.941 | 17.655 | 0,06% | Aktien |
| ADAR1 Capital Management, LLC | $114.080 | 15.500 | 0,05% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $114.028 | 15.493 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $99.735 | 13.551 | 0,04% | Aktien |
| Quadrature Capital Ltd | $97.572 | 13.257 | 0,04% | Aktien |
| CITIGROUP INC | $96.357 | 13.092 | 0,04% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $88.364 | 12.769 | 0,04% | Aktien |
| CWM, LLC | $85.665 | 6.788 | 0,04% | Aktien |
| Invesco Ltd. | $85.656 | 11.638 | 0,04% | Aktien |
| Cerity Partners LLC | $72.091 | 9.795 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $69.707 | 9.471 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $65.335 | 8.877 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $64.856 | 8.812 | 0,03% | Aktien |
| MORGAN STANLEY | $39.494 | 5.366 | 0,02% | Aktien |
| State of Wyoming | $36.903 | 5.014 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $34.489 | 4.686 | 0,02% | Aktien |
| Arax Advisory Partners | $32.958 | 4.478 | 0,01% | Aktien |
| Versant Capital Management, Inc | $31.067 | 4.221 | 0,01% | Aktien |
| Nuveen Asset Management, LLC | $26.454 | 1.530 | 0,01% | Aktien |
| STRS OHIO | $23.552 | 3.200 | 0,01% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $21.874 | 2.972 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $21.462 | 2.916 | 0,01% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $19.784 | 2.688 | 0,01% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $19.435 | 1.540 | 0,01% | Aktien |
| Legal & General Group Plc | $18.807 | 2.557 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $17.789 | 2.417 | 0,01% | Aktien |
| FMR LLC | $15.692 | 2.132 | 0,01% | Aktien |
| FEDERATED HERMES, INC. | $14.484 | 1.968 | 0,01% | Aktien |
Unternehmensinsider 14 Insider · 5 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dipal Doshi | President and CEO | 1. September 2022 A | 221.835 | 0 | 0 | $0 |
| Kory James Wentworth | Chief Financial Officer | 1. September 2022 A | 16.489 | 0 | 0 | $0 |
| Nathan J Dowden | Chief Operating Officer | 1. September 2022 A | 70.525 | 0 | 0 | $0 |
| Natarajan Sethuraman | Chief Scientific Officer | 1. September 2022 A | 162.144 | 0 | 0 | $0 |
| Nerissa Kreher | Chief Medical Officer | 1. September 2022 A | 20.716 | 0 | 0 | $0 |
| Maha Radhakrishnan | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Gina Chapman | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Bernhardt G Zeiher | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Mary Thistle | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Peter S Kim | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| John F Crowley | Direktor | 8. Juni 2023 A | 5.000 | 0 | 0 | $0 |
| Carole Nuechterlein | Direktor | 2. Juni 2022 A | — | 0 | 0 | $0 |
| Todd Foley | Direktor | 2. Juni 2022 A | 4.425.784 | 0 | 0 | $0 |
| Kush Parmar | — | 10. August 2026 S | 2.691.337 | 0 | 5 | $-1.885.964 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar, Scott M. Rocklage | 18. November 2025 | 10,80% | Änderung | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×2 Einreichungen | 26. Juni 2024 | — | Erste Einreichung | Passive Anlage | SEC |
| MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2018, L.P., MPM BioVentures 2018 (B), L.P., MPM Asset Management Investors BV2018 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, Ansbert Gadicke, Luke Evnin, Todd Foley, Edward Hurwitz | 12. November 2021 | — | Erste Einreichung | Passive Anlage | SEC |
| 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Dr. Kush Parmar, Dr. Scott M. Rocklage | 12. November 2021 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 34 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| HAPS · Harbor ETF Trust | 0,16% | 18.286 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 33.055 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 69.412 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,01% | 1.416 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 12.375 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 100.802 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1.340 NS | 31. Mai 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 27.316 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 113.479 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.047 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 800 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.057 NS | 31. Mai 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 742 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 27 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 7.570 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 888 NS | 31. Mai 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 6.979 NS | 31. Mai 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 17.261 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 1.647 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 2.069 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWN · iShares Trust | — | — | 17. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IBB · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13. Juli 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | — | — | 20. Juli 2026 | Täglich |
| IBRN · iShares Trust | — | — | 6. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20. Juli 2026 | Täglich |